Cytostatic activity of oxidized tetracycline in vitro: relevance for the treatment of malignant effusions?
作者信息
Sauter C
机构信息
Department of Medicine, University Hospital, Zürich, Switzerland.
出版信息
Br J Cancer. 1988 May;57(5):514-5. doi: 10.1038/bjc.1988.117.
Abstract
摘要
相似文献
1
Cytostatic activity of oxidized tetracycline in vitro: relevance for the treatment of malignant effusions?氧化四环素的体外细胞抑制活性：对恶性胸腔积液治疗的相关性？
Br J Cancer. 1988 May;57(5):514-5. doi: 10.1038/bjc.1988.117.
2
[Growth-inhibitory activity of minocycline on various tumor cell lines in vitro].[米诺环素对多种肿瘤细胞系的体外生长抑制活性]
Gan To Kagaku Ryoho. 1986 Jul;13(7):2337-41.
3
Tetracycline in the treatment of malignant effusions: evidence for a cytostatic action of the decomposed drug.
Eur J Cancer Clin Oncol. 1987 Jul;23(7):973-7. doi: 10.1016/0277-5379(87)90343-9.
4
Metastatic renal cell carcinoma-associated pleural effusion after coronary artery bypass grafting.冠状动脉搭桥术后转移性肾细胞癌相关胸腔积液
J Am Osteopath Assoc. 2004 May;104(5):215-7.
5
[Hypernephroma cells in pleural effusions].[胸腔积液中的肾细胞癌]
Plucne Bolesti. 1989 Jul-Dec;41(3-4):178-9.
6
Tetracycline and doxycycline inhibit pleural fluid metalloproteinases. A possible mechanism for chemical pleurodesis.
Chest. 1993 Apr;103(4):1113-7. doi: 10.1378/chest.103.4.1113.
7
[Phase II clinical trial of sorafenib plus local chemotherapy in the treatment of metastatic renal cell carcinoma with pleural effusion].
Zhonghua Yi Xue Za Zhi. 2012 Nov 13;92(42):2998-3000. doi: 10.3760/cma.j.issn.0376-2491.2012.42.013.
8
Malignant effusion of chromophobe renal-cell carcinoma: cytological and immunohistochemical findings.嫌色性肾细胞癌的恶性积液：细胞学和免疫组化结果
Diagn Cytopathol. 2012 Jan;40(1):56-61. doi: 10.1002/dc.21599. Epub 2011 Jan 6.
9
[Chemotherapy of renal cell carcinoma: experimental study and clinical effect].[肾细胞癌的化疗：实验研究与临床疗效]
Hinyokika Kiyo. 1988 Nov;34(11):1879-84.
10
Intrapleural tetracycline for malignant pleural effusions.
Chest. 1975 Oct;68(4):510-2. doi: 10.1378/chest.68.4.510.
引用本文的文献
1
Neoplastic pericardial disease: Old and current strategies for diagnosis and management.肿瘤性心包疾病：诊断与管理的过去与当前策略
World J Cardiol. 2010 Sep 26;2(9):270-9. doi: 10.4330/wjc.v2.i9.270.
本文引用的文献
1
[On exfoliative cytology of small quantities of fluids].[关于少量液体的脱落细胞学检查]
Schweiz Med Wochenschr. 1962 Jul 14;92:863-6.
2
Reversible "Faconi syndrome" caused by degraded tetracycline.
JAMA. 1963 Apr 13;184:111-3. doi: 10.1001/jama.1963.03700150065010.
3
Mediation of divalent metal ions in the binding of tetracycline to macromolecules.二价金属离子在四环素与大分子结合中的介导作用。
Nature. 1961 Sep 16;191:1156-8. doi: 10.1038/1911156a0.
4
Storage of tetracycline solutions for peritoneal lavage.
J R Coll Surg Edinb. 1984 Nov;29(6):379-80.
5
Intrapleural tetracycline in malignant pleural effusions. A randomized study.胸膜内注射四环素治疗恶性胸腔积液。一项随机研究。
Cancer. 1983 Feb 15;51(4):752-5. doi: 10.1002/1097-0142(19830215)51:4<752::aid-cncr2820510434>3.0.co;2-7.
6
Tetracycline in the treatment of malignant effusions: evidence for a cytostatic action of the decomposed drug.
Eur J Cancer Clin Oncol. 1987 Jul;23(7):973-7. doi: 10.1016/0277-5379(87)90343-9.
7
Diagnosis and treatment of malignant pleural effusion.恶性胸腔积液的诊断与治疗
Semin Oncol. 1985 Mar;12(1):54-75.
8
[Human renal cell carcinoma in the "nude" mouse: long-term observations (author's transl)].
Beitr Pathol. 1977 Aug;160(4):337-60. doi: 10.1016/s0005-8165(77)80118-2.
9
The pH of sclerosing agents: a determinant of pleural symphysis.硬化剂的pH值：胸膜粘连的一个决定因素。
Chest. 1979 Aug;76(2):198-200. doi: 10.1378/chest.76.2.198.
Zotero 插件